Minocin

Mi·no·cin (m-nsn)

A trademark for the drug minocycline.

---

minocycline hydrochloride

Aknemin (UK), Alti-Minocycline (CA), Arestin, Dentomycin (UK), Dynacin, Sebomin (UK), Gen-Minocycline (CA), Minocin, Novo-Minocycline (CA), Sebren

Pharmacologic class: Tetracycline

Therapeutic class: Anti-infective

Pregnancy risk category D

Action

Binds reversibly to 30S ribosome, inhibiting bacterial protein synthesis

Availability

Capsules: 50 mg, 75 mg, 100 mg

Capsules (pellet-filled): 50 mg, 100 mg

Microspheres (sustained-release): 1 mg

Suspension: 50 mg/5 ml

Tablets: 50 mg, 75 mg, 100 mg

⊘Indications and dosages

➣ Infections caused by susceptible organisms

Adults: Initially, 200 mg P.O. then 100 mg P.O. q 12 hours or 50 mg P.O. q 6 hours

Children ages 8 and older: 4 mg/kg P.O. followed by 2 mg/kg q 12 hours

➣ Gonorrhea in penicillin-sensitive patients

Adults: Initially, 200 mg P.O., then 100 mg q 12 hours for at least 4 days

➣ Uncomplicated gonococcal urethritis in men

Adults: 100 mg P.O. q 12 hours for 5 days

➣ Syphilis

Adults: Initially, 200 mg P.O., then 100 mg q 12 hours for 10 to 15 days

➣ Acne

Adults: 50 mg P.O. one to three times daily

Dosage adjustment

• Renal impairment

Contraindications

• Hypersensitivity to drug, its components, or tetracyclines

Precautions

Use cautiously in:
• sulfite sensitivity, renal disease, hepatic impairment, nephrogenic diabetes insipidus
• cachectic or debilitated patients
• pregnant (last half of pregnancy) or breastfeeding patients
• children younger than age 8 (not recommended).

Administration

• Ask patient about sulfite sensitivity before giving.
• Give with 8 oz. of water, with or without food.
• Know that drug is used in penicillin-sensitive patients.

Route	Onset	Peak	Duration
P.O.	Unknown	1-4 hr	Unknown

Adverse reactions

CNS: headache

CV: pericarditis

EENT: pharyngitis

GI: nausea, vomiting, diarrhea, oral candidiasis, stomatitis, mouth ulcers

GU: bladder or vaginal yeast infection

Metabolic: eosinophilia, hemolytic anemia, thrombocytopenia

Skin: photosensitivity, rash

Other: dental caries; dental infection; gingivitis; periodontitis; tooth disorder, pain, or discoloration; superinfection; hypersensitivity reactions including anaphylaxis

Interactions

Drug-drug. Adsorbent antidiarrheals: decreased minocycline absorption

Antacids containing aluminum, calcium, or magnesium; calcium, iron, and magnesium supplements; sodium bicarbonate: decreased minocycline absorption

Cholestyramine, colestipol: decreased oral absorption of minocycline

Hormonal contraceptives: decreased contraceptive efficacy

Methoxyflurane: nephrotoxicity

Penicillin: interference with bactericidal action of penicillin

Sucralfate: blocked absorption of minocycline

Warfarin: increased anticoagulant effect

Drug-diagnostic tests. Alanine aminotransferase, alkaline phosphatase, amylase, aspartate aminotransferase, bilirubin, blood urea nitrogen: increased levels

Hemoglobin, platelets, neutrophils, white blood cells: decreased levels

Urinary catecholamines: false elevation

Drug-food. Dairy products: decreased minocycline absorption

Drug-behaviors. Alcohol use: decreased antibiotic effect

Sun exposure: increased risk of photosensitivity reaction

Patient monitoring

• Assess patient's oral health closely for dental problems.
• Monitor patient for superinfection, especially oral, bladder, and vaginal yeast infections.
• Evaluate CBC and renal and liver function tests frequently.
☞ Watch closely for hypersensitivity reactions, including anaphylaxis.

Patient teaching

• Tell patient he may take with or without food, followed by a full glass of water. Instruct him to space doses evenly over 24 hours and to take one dose 1 hour before bedtime.
• Advise patient not to take with antacids or iron, calcium, or magnesium products.
☞ Instruct patient to immediately report fever, chills, skin rash, unusual bleeding or bruising, sore throat, or mouth pain or discomfort.
• Stress importance of good oral hygiene to minimize adverse oral and dental effects.
• Tell patient to complete entire course of therapy even after symptoms improve.
☞ Caution patient not to use outdated minocycline because it may cause serious kidney disease.
• Inform female patient that drug may make hormonal contraceptives ineffective. Urge her to use barrier contraception.
• Tell pregnant patient that drug may stain fetus' teeth if taken during last half of pregnancy.
• Advise female patient to tell prescriber if she's breastfeeding.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, foods, and behaviors mentioned above.